Eli Lilly Gets $177M Teva Migraine Drug Patent Verdict Tossed
A Massachusetts federal judge overturned a $176.5 million migraine drug patent infringement verdict that Teva Pharmaceuticals won against Eli Lilly & Co., finding Tuesday that the three patents related to Teva's product Ajovy...To view the full article, register now.
Already a subscriber? Click here to view full article